At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

New research casts doubt on current advice recommending AF patients wait up to 14 days to receive anticoagulants after a ...

The Phase III ECZTEND study reported that patients treated with Adbry demonstrated long term safety and efficacy for up to ...

The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological ...

Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at decarbonisation across the healthcare ...

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’s Prevnar 20 to 50 years down from 65.

Novo Nordisk has asked the FDA to add semaglutide to a list that would effectively block manufacturing of copycat versions of ...

Experimental new therapies, regulatory changes, sustainability imperatives – biomanufacturers are navigating a changing ...